Endo International PLC Company Profile (NASDAQ:ENDP)

About Endo International PLC

Endo International PLC logoEndo International PLC, formerly Endo Health Solutions Inc. is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel. The Company operates in three segments: Endo Pharmaceuticals, Qualitest and AMS. In June 2014, the Company's subsidiary, Endo Pharmaceuticals sold its pharmaceutical drug discovery platform to AsanaBioSciences, LLC. In June 2014, Asana BioSciences, LLC, an independent member of Amneal Alliance of Companies, acquired early-stage branded pharmaceutical discovery platform of Endo Pharmaceuticals, a subsidiary of Endo International plc. In June 2014, Trendlines Group acquired intellectual property developed within the framework of an R&D agreement with the Company. In July 2014, it acquired Grupo Farmaceutico Somar.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: ENDP
  • CUSIP: 29264F20
Key Metrics:
  • Previous Close: $13.08
  • 50 Day Moving Average: $13.52
  • 200 Day Moving Average: $17.69
  • 52-Week Range: $222,876,000.00 - $11.37
  • Trailing P/E Ratio: 1.44
  • Foreward P/E Ratio: 3.02
  • P/E Growth: -1.14
  • Market Cap: $2915.23B
  • Outstanding Shares: 222,876,000
  • Beta: 0.54
Profitability:
  • Net Margins: -3.32%
  • Return on Equity: 15.95%
  • Return on Assets: 5.24%
Debt:
  • Debt-to-Equity Ratio: 1.35%
  • Current Ratio: 0.84%
  • Quick Ratio: 0.61%
Additional Links:
Companies Related to Endo International PLC:

Analyst Ratings

Consensus Ratings for Endo International PLC (NASDAQ:ENDP) (?)
Ratings Breakdown: 11 Hold Ratings, 10 Buy Ratings
Consensus Rating:Hold (Score: 2.48)
Consensus Price Target: $27.55 (110.63% upside)

Analysts' Ratings History for Endo International PLC (NASDAQ:ENDP)
Show:
DateFirmActionRatingPrice TargetDetails
2/6/2017Barclays PLCLower Price TargetEqual Weight$22.00 -> $15.00View Rating Details
1/31/2017Susquehanna Bancshares IncUpgradeNeutral -> PositiveView Rating Details
1/31/2017MizuhoLower Price TargetBuy$25.00 -> $15.00View Rating Details
1/30/2017RBC Capital MarketsReiterated RatingSector Perform$18.00 -> $15.00View Rating Details
1/27/2017Piper Jaffray CompaniesSet Price TargetHold$12.00View Rating Details
1/20/2017J P Morgan Chase & CoDowngradeOverweight -> Neutral$20.00View Rating Details
1/5/2017Citigroup Inc.DowngradeBuy -> Neutral$25.00 -> $20.00View Rating Details
12/11/2016JMP SecuritiesReiterated RatingOutperform$34.00View Rating Details
12/7/2016Oppenheimer Holdings, Inc.Reiterated RatingMarket PerformView Rating Details
11/11/2016BMO Capital MarketsReiterated RatingHoldView Rating Details
11/9/2016Royal Bank Of CanadaLower Price TargetOutperform$26.00 -> $21.00View Rating Details
10/15/2016GuggenheimReiterated RatingBuy$35.00View Rating Details
9/29/2016Northland SecuritiesUpgradeMarket Perform -> Outperform$27.00View Rating Details
9/23/2016Leerink SwannReiterated RatingMarket Perform$22.00View Rating Details
9/8/2016Morgan StanleySet Price TargetHold$15.00 -> $16.00View Rating Details
6/29/2016Deutsche Bank AGReiterated RatingBuy$30.00View Rating Details
6/6/2016Goldman Sachs Group, Inc. (The)Initiated CoverageNeutral$20.00View Rating Details
5/18/2016Stifel NicolausLower Price TargetBuy$75.00 -> $25.00View Rating Details
4/2/2016NomuraReiterated RatingBuyView Rating Details
3/18/2016William BlairReiterated RatingHold$35.00View Rating Details
3/1/2016Canaccord GenuityReiterated RatingBuy$67.00View Rating Details
11/13/2015Standpoint ResearchUpgradeHold -> Buy$75.00View Rating Details
6/3/2015Raymond James Financial, Inc.Initiated CoverageMarket PerformView Rating Details
5/22/2015Cantor FitzgeraldBoost Price TargetHold$80.00 -> $92.00View Rating Details
3/3/2015Keefe, Bruyette & WoodsBoost Price TargetOutperform$94.00 -> $101.00View Rating Details
(Data available from 2/19/2015 forward)

Earnings

Earnings History for Endo International PLC (NASDAQ:ENDP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2017ListenView Earnings Details
11/8/2016Q316$0.81$1.01$862.47 million$894.30 millionViewListenView Earnings Details
8/8/2016Q216$0.74$0.86$873.50 million$921.00 millionViewListenView Earnings Details
5/5/2016Q116$1.04$1.08$960.96 million$963.54 millionViewListenView Earnings Details
2/29/2016Q415$1.27$1.36$1.07 billion$1.07 billionViewListenView Earnings Details
11/5/2015Q315$1.00$1.02$736.16 million$746.00 millionViewListenView Earnings Details
8/10/2015Q215$1.02$1.08$727.45 million$735.00 millionViewListenView Earnings Details
5/11/2015Q115$1.07$1.17$714.42 million$714.00 millionViewListenView Earnings Details
3/2/2015Q414$1.12$1.16$780.44 million$800.00 millionViewListenView Earnings Details
11/5/2014Q314$0.99$1.15$721.11 million$764.00 millionViewListenView Earnings Details
7/31/2014Q214$0.88$1.06$644.60 million$719.00 millionViewListenView Earnings Details
5/1/2014Q114$0.84$0.92$608.86 million$595.00 millionViewListenView Earnings Details
2/28/2014Q413$0.93$0.96$620.90 million$584.95 millionViewListenView Earnings Details
11/7/2013Q313$1.11$1.34$695.63 million$715.00 millionViewListenView Earnings Details
8/6/2013Q2 2013$1.15$1.42$721.01 million$766.51 millionViewListenView Earnings Details
5/7/2013Q1 2013$1.08$1.09$737.79 million$709.00 millionViewListenView Earnings Details
2/28/2013Q4 2012$1.54$1.62$807.98 million$801.06 millionViewListenView Earnings Details
11/5/2012Q312$1.26$1.28$788.53 million$750.50 millionViewN/AView Earnings Details
8/7/2012$1.19$1.27ViewN/AView Earnings Details
5/1/2012$0.86$0.87ViewN/AView Earnings Details
2/24/2012$1.32$1.40ViewN/AView Earnings Details
10/27/2011$1.28$1.25ViewN/AView Earnings Details
8/9/2011$1.06$1.05ViewN/AView Earnings Details
4/28/2011$1.00$1.00ViewN/AView Earnings Details
2/28/2011$0.97$1.06ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Endo International PLC (NASDAQ:ENDP)
Current Year EPS Consensus Estimate: $4.57 EPS
Next Year EPS Consensus Estimate: $4.33 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$1.05$1.15$1.09
Q2 20163$0.74$1.24$0.92
Q3 20163$0.80$0.85$0.82
Q4 20163$1.59$1.67$1.64
Q1 20172$1.41$1.52$1.47
Q2 20172$0.99$1.02$1.01
Q3 20172$0.83$0.92$0.88
Q4 20172$0.87$1.00$0.94
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Endo International PLC (NASDAQ:ENDP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Endo International PLC (NASDAQ:ENDP)
Insider Ownership Percentage: 0.70%
Institutional Ownership Percentage: 95.50%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/15/2016Roger H. KimmelDirectorSell14,000$17.38$243,320.00View SEC Filing  
5/11/2016Arthur J HigginsDirectorBuy5,000$13.80$69,000.00View SEC Filing  
5/10/2016Arthur J HigginsDirectorBuy11,000$15.42$169,620.00View SEC Filing  
5/10/2016Paul CampanelliInsiderBuy13,000$15.53$201,890.00View SEC Filing  
3/17/2016William SpenglerDirectorBuy1,000$29.20$29,200.00View SEC Filing  
3/16/2016William SpenglerDirectorBuy1,000$35.24$35,240.00View SEC Filing  
3/14/2016Roger H KimmelDirectorBuy1,125$41.94$47,182.50View SEC Filing  
3/7/2016Matthew Joseph MalettaVPBuy500$44.48$22,240.00View SEC Filing  
3/7/2016Silva Rajiv DeCEOBuy2,250$44.50$100,125.00View SEC Filing  
3/1/2016Nancy J. HutsonDirectorSell3,413$42.19$143,994.47View SEC Filing  
11/12/2015Shane CookeDirectorBuy4,000$57.13$228,520.00View SEC Filing  
11/11/2015Michael HyattDirectorSell8,000$55.48$443,840.00View SEC Filing  
11/11/2015Paul CampanelliinsiderBuy2,100$55.69$116,949.00View SEC Filing  
11/11/2015Silva Rajiv DeCEOBuy9,006$55.52$500,013.12View SEC Filing  
11/11/2015Suketu UpadhyayCFOBuy4,450$56.37$250,846.50View SEC Filing  
11/11/2015Susan HallEVPBuy1,000$55.35$55,350.00View SEC Filing  
6/16/2015Arthur J HigginsDirectorBuy2,500$81.10$202,750.00View SEC Filing  
4/8/2015Caroline B ManogueVPSell105,562$91.90$9,701,147.80View SEC Filing  
11/14/2014Suketu UpadhyayCFOBuy3,700$66.94$247,678.00View SEC Filing  
8/5/2014Arthur J HigginsDirectorBuy3,500$65.65$229,775.00View SEC Filing  
6/9/2014John DeluccaDirectorSell6,764$68.83$465,566.12View SEC Filing  
5/29/2014Caroline B ManogueVPSell175,033$72.02$12,605,876.66View SEC Filing  
5/1/2014John DeluccaDirectorSell8,094$66.31$536,713.14View SEC Filing  
4/1/2014John DeluccaDirectorSell10,384$68.46$710,888.64View SEC Filing  
3/10/2014Arthur HigginsDirectorBuy5,000$73.00$365,000.00View SEC Filing  
3/10/2014Ivan GergelEVPSell75,637$72.47$5,481,413.39View SEC Filing  
8/26/2013Caroline ManogueVPSell145,592$39.40$5,736,324.80View SEC Filing  
8/8/2013Roger KimmelDirectorBuy5,478$36.50$199,947.00View SEC Filing  
4/9/2013Caroline B ManogueVPSell35,000$35.00$1,225,000.00View SEC Filing  
11/12/2012David HolveckCEOBuy7,425$26.84$199,287.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Endo International PLC (NASDAQ:ENDP)
DateHeadline
News IconSADIF Analytics releases new summary due diligence report for Endo International PLC ($ENDP). (NASDAQ:ENDP)
reports.pr-inside.com - February 16 at 4:19 PM
marketrealist.com logoHealth Care Sector Led the S&P 500’s Rally on February 15 (NASDAQ:ENDP)
marketrealist.com - February 16 at 4:19 PM
finance.yahoo.com logoEndo to Announce Fourth-Quarter and Full-Year 2016 Financial Results (NASDAQ:ENDP)
finance.yahoo.com - February 13 at 8:28 AM
News IconEndo International plc (ENDP) moves down at least -11.46% on its earnings reaction day - Post Analyst (NASDAQ:ENDP)
postanalyst.com - February 10 at 10:29 PM
blogs.barrons.com logoIs More Downside Ahead For Teva Pharmaceutical? (NASDAQ:ENDP)
blogs.barrons.com - February 10 at 5:28 PM
sg.finance.yahoo.com logoCanada's TMX seeks part of Saudi Aramco listing (NASDAQ:ENDP)
sg.finance.yahoo.com - February 8 at 5:28 PM
News IconFeatured Stock to Focus: Endo International plc (NASDAQ:ENDP) (NASDAQ:ENDP)
mlbinjurynews.com - February 7 at 6:10 PM
seekingalpha.com logoEndo International: Play On The Dip (NASDAQ:ENDP)
seekingalpha.com - February 1 at 5:31 PM
News IconThe Leerink Swann Comments on Endo International PLC's FY2017 Earnings (ENDP) (NASDAQ:ENDP)
xboxonezone.com - February 1 at 5:31 PM
News IconEndo International PLC reiterated as Buy By Mizuho Securities (NASDAQ:ENDP)
itapunta.com - February 1 at 3:43 AM
News IconEndo International plc (NASDAQ:ENDP) closed with a change of 0.25% (NASDAQ:ENDP)
interiordesignfuture.com - February 1 at 3:43 AM
News IconThe Endo International PLC (ENDP) Stock Rating Lowered by JPMorgan Chase & Co (NASDAQ:ENDP)
ekosvoice.com - February 1 at 3:43 AM
newswire.ca logoEndo Announces U.S. FDA Approval of Ephedrine Sulfate Injection, USP - Canada NewsWire (press release) (NASDAQ:ENDP)
www.newswire.ca - January 31 at 5:39 PM
streetinsider.com logoEndo International plc (ENDP) PT Lowered to $15 at Mizuho Securities - StreetInsider.com (NASDAQ:ENDP)
www.streetinsider.com - January 31 at 5:39 PM
blogs.barrons.com logoEndo International: We Believe? (NASDAQ:ENDP)
blogs.barrons.com - January 31 at 5:39 PM
streetinsider.com logoEndo Int'l (ENDP) Announces FDA Approval of Ephedrine Sulfate Injection (NASDAQ:ENDP)
www.streetinsider.com - January 31 at 1:32 AM
News IconWorth Watching Stock: Endo International plc (NASDAQ:ENDP) (NASDAQ:ENDP)
vgtoday.net - January 31 at 1:32 AM
smarteranalyst.com logoEndo International plc – Ordinary Shares (ENDP) Wins FDA Approval of Ephedrine Sulfate Injection, USP (NASDAQ:ENDP)
www.smarteranalyst.com - January 31 at 1:31 AM
streetinsider.com logoEndo International (ENDP) PT, Estimates Lowered at JMP - StreetInsider.com (NASDAQ:ENDP)
www.streetinsider.com - January 30 at 8:30 PM
streetinsider.com logoEndo International (ENDP) Ephedrine approval Sooner than Expected, Stifel Notes; Incrementaly Postive for ENDP ... - StreetInsider.com (NASDAQ:ENDP)
www.streetinsider.com - January 30 at 3:30 PM
News IconNoticeable Stock: Endo International plc (NASDAQ:ENDP), Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - The Newburgh Press (NASDAQ:ENDP)
newburghpress.com - January 27 at 6:37 PM
News IconEndo International plc (NASDAQ:ENDP) Stock current Trends Analysis (NASDAQ:ENDP)
hypelee.com - January 26 at 11:19 PM
News IconStock Analysis Review: Endo International plc (NASDAQ:ENDP) (NASDAQ:ENDP)
avauncer.com - January 26 at 11:19 PM
streetinsider.com logoEndo (ENDP) Announces Restructuring; to Reduce Work Force by ... - StreetInsider.com (NASDAQ:ENDP)
www.streetinsider.com - January 26 at 6:18 PM
finance.yahoo.com logo6:32 am Endo Intl initiates restructuring program; will reduce workforce, expects to realize approximately $40-50 million in annual run rate pre-tax cost savings by 4Q17 (NASDAQ:ENDP)
finance.yahoo.com - January 26 at 6:18 PM
biz.yahoo.com logoENDO INTERNATIONAL PLC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Financial Statements an (NASDAQ:ENDP)
biz.yahoo.com - January 26 at 6:18 PM
marketwatch.com logoEndo to cut 90 jobs as part of drugmaker's restructuring (NASDAQ:ENDP)
www.marketwatch.com - January 26 at 6:18 PM
finance.yahoo.com logoWeitz Funds Comments on Endo International (NASDAQ:ENDP)
finance.yahoo.com - January 26 at 6:18 PM
News IconChecking on CCI, MA, RSI and ADX for Endo International Plc (ENDP.TO) - Rives Journal (NASDAQ:ENDP)
rivesjournal.com - January 25 at 11:15 PM
News IconMost Active Volume Stock: Endo International plc (NASDAQ:ENDP) (NASDAQ:ENDP)
flapship.com - January 25 at 6:14 PM
News IconRecent analysts Ratings: Endo International plc (NASDAQ:ENDP) (NASDAQ:ENDP)
larampadinapoli.com - January 25 at 6:14 PM
investopedia.com logoEndo Settles FTC 'Pay-for-Delay' Allegations (NASDAQ:ENDP)
www.investopedia.com - January 25 at 6:14 PM
News IconEndo International Release: Pharma Announces Agreement To Resolve FTC Investigation And Litigation (NASDAQ:ENDP)
www.biospace.com - January 24 at 5:37 PM
thestreet.com logoBiotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo (NASDAQ:ENDP)
us.rd.yahoo.com - January 24 at 5:37 PM
News IconAnalysts Pounding The Pavement on Endo International plc (NASDAQ:ENDP): Consensus Update - Wall Street Beacon (NASDAQ:ENDP)
wsbeacon.com - January 24 at 3:22 AM
marketnewsvideo.com logoAaron's Moves Up In Market Cap Rank, Passing Endo International (NASDAQ:ENDP)
www.marketnewsvideo.com - January 23 at 5:19 PM
smarteranalyst.com logoCompany Update (NASDAQ:ENDP): Endo International plc – Ordinary Shares ... (NASDAQ:ENDP)
www.smarteranalyst.com - January 23 at 5:19 PM
us.rd.yahoo.com logo2:18 pm Endo confirms agreement to resolve FTC investigation & litigation through a 10-year stipulated order for permanent injunction; no monetary payment & no admission of wrongdoing by Endo (NASDAQ:ENDP)
us.rd.yahoo.com - January 23 at 5:19 PM
us.rd.yahoo.com logoAllergan Stock is Still Struggling Amid FTC Ruling (NASDAQ:ENDP)
us.rd.yahoo.com - January 23 at 5:19 PM
News IconTrading Spotlight: Zooming in on Shares of Endo International Plc (ENDP.TO) - Rives Journal (NASDAQ:ENDP)
rivesjournal.com - January 23 at 5:19 PM
News IconMovers of most recent trading session: Endo International plc (NASDAQ:ENDP), CF Industries Holdings, Inc. (NYSE:CF) - The Newburgh Press (NASDAQ:ENDP)
newburghpress.com - January 23 at 5:19 PM
News IconEndo International plc. (Nasdaq: ENDP) Settles FTC Lawsuit – Shares Continue Slide - StockNewsUnion (NASDAQ:ENDP)
stocknewsunion.com - January 23 at 5:19 PM
bizjournals.com logoFTC, Endo propose agreement to resolve pay-for-delay dispute (NASDAQ:ENDP)
www.bizjournals.com - January 23 at 5:19 PM
bizjournals.com logoFTC, Endo propose agreement to resolve pay-for-delay dispute (NASDAQ:ENDP)
www.bizjournals.com - January 23 at 5:19 PM
investors.com logoEndo Resolves FTC Antitrust Suit, But Allergan Hanging; Stocks Mixed (NASDAQ:ENDP)
www.investors.com - January 23 at 5:19 PM
investors.com logoEndo Resolves FTC Antitrust Suit, But Allergan Hanging; Stocks Mixed (NASDAQ:ENDP)
www.investors.com - January 23 at 5:19 PM
finance.yahoo.com logoU.S. FTC reaches pay-for-delay settlement with Endo (NASDAQ:ENDP)
finance.yahoo.com - January 23 at 5:19 PM
finance.yahoo.com logoU.S. FTC reaches pay-for-delay settlement with Endo (NASDAQ:ENDP)
finance.yahoo.com - January 23 at 5:19 PM
News IconEndo International Plc ENDP Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:ENDP)
www.bioportfolio.com - January 22 at 9:53 PM
News IconWill The Needle Move For Endo International plc (NASDAQ:ENDP) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:ENDP)
wsbeacon.com - January 20 at 11:16 PM

Social

What is Endo International PLC's stock symbol?

Endo International PLC trades on the NASDAQ under the ticker symbol "ENDP."

Where is Endo International PLC's stock going? Where will Endo International PLC's stock price be in 2017?

21 analysts have issued twelve-month price objectives for Endo International PLC's stock. Their predictions range from $12.00 to $80.00. On average, they expect Endo International PLC's stock price to reach $27.55 in the next year.

When will Endo International PLC announce their earnings?

Endo International PLC is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.

Who owns Endo International PLC stock?

Endo International PLC's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include State Street Corp (4.33%), Systematic Financial Management LP (1.18%), New York State Teachers Retirement System (0.15%), Russell Investments Group Ltd. (0.11%), Gabelli Funds LLC (0.11%) and Barings LLC (0.07%). Company insiders that own Endo International PLC stock include Arthur J Higgins, Caroline B Manogue, Matthew Joseph Maletta, Michael Hyatt, Nancy J Hutson, Paul Campanelli, Roger H Kimmel, Shane Cooke, Silva Rajiv De, Suketu Upadhyay, Susan Hall and William Spengler.

Who sold Endo International PLC stock? Who is selling Endo International PLC stock?

Endo International PLC's stock was sold by a variety of institutional investors in the last quarter, including Janus Capital Management LLC, Van ECK Associates Corp and Comerica Bank. Company insiders that have sold Endo International PLC stock in the last year include Nancy J Hutson and Roger H Kimmel.

Who bought Endo International PLC stock? Who is buying Endo International PLC stock?

Endo International PLC's stock was acquired by a variety of institutional investors in the last quarter, including Systematic Financial Management LP, State Street Corp, Russell Investments Group Ltd., Gabelli Funds LLC, Flinton Capital Management LLC, Tyers Asset Management LLC, New York State Teachers Retirement System and Barings LLC. Company insiders that have bought Endo International PLC stock in the last two years include Arthur J Higgins, Matthew Joseph Maletta, Paul Campanelli, Roger H Kimmel, Shane Cooke, Silva Rajiv De, Suketu Upadhyay, Susan Hall and William Spengler.

How do I buy Endo International PLC stock?

Shares of Endo International PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Endo International PLC stock cost?

One share of Endo International PLC stock can currently be purchased for approximately $13.08.

Endo International PLC (NASDAQ:ENDP) Chart for Sunday, February, 19, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Endo International PLC (NASDAQ:ENDP)

Earnings History Chart

Earnings by Quarter for Endo International PLC (NASDAQ:ENDP)

Dividend History Chart

Dividend Payments by Quarter for Endo International PLC (NASDAQ:ENDP)

Last Updated on 2/19/2017 by MarketBeat.com Staff